A
Amelie de Gregorio
Researcher at University of Ulm
Publications - 35
Citations - 296
Amelie de Gregorio is an academic researcher from University of Ulm. The author has contributed to research in topics: Breast cancer & Medicine. The author has an hindex of 8, co-authored 29 publications receiving 152 citations.
Papers
More filters
Journal ArticleDOI
Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer During Follow-Up and Prognosis.
Elisabeth Trapp,Elisabeth Trapp,Wolfgang Janni,Christian Schindlbeck,Julia Jückstock,Ulrich Andergassen,Amelie de Gregorio,Marianna Alunni-Fabbroni,M Tzschaschel,Arkadius Polasik,Julian Koch,Thomas W. P. Friedl,Peter A. Fasching,Lothar Haeberle,Tanja Fehm,Andreas Schneeweiss,Matthias W. Beckmann,Klaus Pantel,Volkmar Mueller,Brigitte Rack,Christoph Scholz +20 more
TL;DR: The presence of CTCs 2 years after chemotherapy was associated with decreased OS and DFS, and active individualized surveillance strategies for breast cancer survivors based on biomarkers should be reconsidered.
Journal ArticleDOI
Seroma in breast surgery: all the surgeons fault?
Florian Ebner,Thomas W. P. Friedl,Amelie de Gregorio,Krisztian Lato,Inga Bekes,Wolfgang Janni,Nikolaus de Gregorio +6 more
TL;DR: The most important factors for seroma production are extent and duration of breast surgery and NAC and IORT.
Journal ArticleDOI
Persistence of circulating tumor cells in high risk early breast cancer patients five years after adjuvant chemotherapy and late recurrence: Results from the adjuvant SUCCESS A trial.
Wolfgang Janni,Brigitte Rack,Peter A. Fasching,Lothar Haeberle,Hans Tesch,Ralf Lorenz,Fabienne Schochter,M Tzschaschel,Amelie de Gregorio,Tanja Fehm,Volkmar Müller,Andreas Schneeweiss,Werner Lichtenegger,Matthias W. Beckmann,Christoph Scholz,Klaus Pantel,Thomas W. P. Friedl +16 more
TL;DR: This data indicates that circulating tumor cells (CTCs) are of prognostic relevance in early as well as metastatic breast cancer and the use of these cells in diagnosis and prognosis of these cancers is warranted.
Journal ArticleDOI
Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma – What is the Role of Liquid Biopsy in Breast Cancer?
Arkadius Polasik,Marie Tzschaschel,Fabienne Schochter,Amelie de Gregorio,Thomas W. P. Friedl,Brigitte Rack,Andreas D. Hartkopf,Peter A. Fasching,Andreas Schneeweiss,Volkmar Müller,Jens Huober,Wolfgang Janni,Tanja Fehm +12 more
TL;DR: Repeated testing for CTCs and ctDNA, or regular so-called “liquid biopsy”, can be performed easily at any stage during the course of disease, and allows definition of tumour characteristics and heterogeneity that may be associated with treatment resistance.
Journal ArticleDOI
Prehabilitation in gynecological surgery? What do gynecologists know and need to know.
Florian Ebner,Sebastian Schulz,Amelie de Gregorio,Sophia Volz,Jürgen M. Steinacker,Wolfgang Janni,Stephanie Otto +6 more
TL;DR: There seems to be a benefit for earlier discharge if patients undergo prehabilitation, but a gynecologic viewpoint still needs establishing and further studies are needed to clarify the benefit for the patients.